Age-dependent interaction between atopy and eosinophils in asthma cases: results from NHANES 2005-2006

被引:23
作者
Arbes, S. J., Jr. [1 ]
Calatroni, A. [1 ]
Mitchell, H. E. [1 ]
Gergen, P. J. [2 ]
机构
[1] Rho Fed Syst Div Inc, Chapel Hill, NC USA
[2] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA
关键词
asthma; atopy; eosinophils; epidemiology; immunoglobulin E; survey; MEPOLIZUMAB;
D O I
10.1111/cea.12069
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
Background Atopy is an established risk factor for asthma, and an elevated eosinophil level is a hallmark of atopic and non-atopic asthma. Whether atopy and eosinophils act independently or interact to influence asthma has clinical and public health implications. Objective To investigate the relationship between atopy and eosinophils in asthma. Methods Data on current asthma, atopy (IgE positive to 1 allergen), and blood eosinophil percent (dichotomized at the median) were obtained for persons aged 6years from the National Health and Nutrition Examination Survey 20052006. Interaction on an additive scale was evaluated by estimating the prevalences of asthma for combinations of atopy (yes or no) and eosinophil percent (high or low) and calculating the excess prevalence due to interaction. Results For all ages combined, the adjusted prevalences of asthma were 4.6%, 7.6%, 6.9% and 17.2% for persons with neither factor, atopy alone, a high eosinophil percent alone and both factors respectively. The excess prevalence of asthma due to interaction was 7.2%, indicating synergism. The excess prevalence was greatest in children aged 617years (15.3%), and it decreased with each older age category until it was absent in adults aged 55years (0.2%). In children, 94% of asthma cases attributable to the 2 factors were attributable to the interaction, whereas in the oldest adults, no cases were attributable to the interaction. Conclusions and Clinical Relevance Interaction between atopy and an elevated eosinophil level in asthma cases was very strong in children but absent in the oldest adults, which suggests different mechanistic pathways for these factors by age and supports the notion that asthma is a heterogeneous disease. In addition, the age-dependent interaction between the factors has potential implications for the selection of asthma patients for treatments that would target either IgE or a high eosinophil level.
引用
收藏
页码:544 / 551
页数:8
相关论文
共 10 条
[1]
Asthma cases attributable to atopy: Results from the third national health and nutrition examination survey [J].
Arbes, Samuel J., Jr. ;
Gergen, Peter J. ;
Vaughn, Ben ;
Zeldin, Darryl C. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (05) :1139-1145
[2]
Sensitization to common allergens and its association with allergic disorders at age 4 years: A whole population birth cohort study [J].
Arshad, SH ;
Tariq, SM ;
Matthews, S ;
Hakim, E .
PEDIATRICS, 2001, 108 (02) :art. no.-e33
[3]
Advances in immunology - Asthma [J].
Busse, WW ;
Lemanske, RF .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :350-362
[4]
BUSSE WW, 1992, ANN ALLERGY, V68, P286
[5]
THE EOSINOPHIL AND THE PATHOPHYSIOLOGY OF ASTHMA [J].
FRIGAS, E ;
GLEICH, GJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (04) :527-537
[6]
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma [J].
Haldar, Pranabashis ;
Brightling, Christopher E. ;
Hargadon, Beverley ;
Gupta, Sumit ;
Monteiro, William ;
Sousa, Ana ;
Marshall, Richard P. ;
Bradding, Peter ;
Green, Ruth H. ;
Wardlaw, Andrew J. ;
Pavord, Ian D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :973-984
[7]
Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation [J].
Miranda, C ;
Busacker, A ;
Balzar, S ;
Trudeau, J ;
Wenzel, SE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :101-108
[8]
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia [J].
Nair, Parameswaran ;
Pizzichini, Marcia M. M. ;
Kjarsgaard, Melanie ;
Inman, Mark D. ;
Efthimiadis, Ann ;
Pizzichini, Emilio ;
Hargreave, Frederick E. ;
O'Byrne, Paul M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :985-993
[9]
Rothman KJ, 1986, MODERN EPIDEMIOLOGY
[10]
PERIPHERAL EOSINOPHIL COUNTS AS A MARKER OF DISEASE-ACTIVITY IN INTRINSIC AND EXTRINSIC-ASTHMA [J].
ULRIK, CS .
CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (09) :820-827